Stockreport

Gossamer Bio GAAP EPS of -$0.21 misses by $0.02, revenue of $13.29M beats by $6.91M [Seeking Alpha]

Gossamer Bio, Inc.  (GOSS) 
Last gossamer bio, inc. earnings: 3/24 07:00 am Check Earnings Report
PDF Gossamer Bio: Bullish Ahead Of Seralutinib's Phase 3 Readout Gossamer Bio: A Critical Year Ahead Gossamer Bio secures option to acquire Respira Therapeutics Gossa [Read more]